Tuberculosis, Lung Infections, and Respiratory Care

About the Conference

Welcome to the 7th World Congress on Tuberculosis, Lung Infections, and Respiratory Care, a premier international gathering dedicated to advancing research, clinical practice, prevention, diagnosis, treatment, and innovation in tuberculosis, respiratory infections, pulmonary medicine, and respiratory healthcare. Taking place in Paris, France, on April 29–30, 2027, this prestigious two-day congress will bring together pulmonologists, respiratory physicians, infectious disease specialists, researchers, clinicians, healthcare professionals, academicians, public health experts, and healthcare leaders to explore the latest developments shaping the future of respiratory health.

Join a global community of pulmonologists, respiratory physicians, infectious disease specialists, tuberculosis specialists, thoracic physicians, respiratory therapists, researchers, academicians, public health professionals, epidemiologists, clinicians, and healthcare experts as they share scientific knowledge, present research findings, discuss emerging challenges, and exchange innovative approaches to improve the prevention, diagnosis, management, and treatment of tuberculosis and respiratory diseases worldwide.

Why Attend?

• Gain valuable insights from expert-led sessions covering tuberculosis, pulmonary infections, respiratory diseases, infectious lung diseases, clinical pulmonology, and respiratory medicine.
• Explore the latest developments in TB diagnosis and treatment, multidrug-resistant tuberculosis, drug-resistant infections, antimicrobial resistance, respiratory infections, and infection prevention and control.
• Learn about advances in pulmonary diagnostics, respiratory imaging, molecular testing, biomarkers, artificial intelligence, digital health, and emerging diagnostic technologies.
• Engage in scientific discussions with global professionals contributing to advances in respiratory medicine, lung health, infectious disease management, and patient-centered respiratory care.
• Build valuable professional connections with experts from hospitals, universities, research institutions, public health organizations, clinical laboratories, healthcare systems, and the pharmaceutical and biotechnology industries.
• Showcase your research findings, clinical experiences, case studies, innovative approaches, and scientific developments through oral presentations, poster presentations, and interactive scientific sessions.
• Discover emerging therapeutic approaches, treatment strategies, technologies, and healthcare solutions aimed at improving outcomes for patients with tuberculosis, lung infections, and respiratory disorders.
• Expand your professional knowledge and stay informed about evidence-based practices, current research, global respiratory health challenges, and future directions in pulmonary and infectious disease care.

Who Should Participate?

• Pulmonologists and Respiratory Physicians
• Tuberculosis Specialists and Physicians
• Infectious Disease Specialists
• Thoracic Physicians and Specialists
• Respiratory Therapists and Respiratory Care Professionals
• Pulmonary and Critical Care Specialists
• Internal Medicine Physicians
• Clinical Researchers and Scientists
• Epidemiologists and Public Health Professionals
• Microbiologists and Laboratory Specialists
• Respiratory and Infectious Disease Researchers
• Healthcare Professionals and Hospital Specialists
• Academicians, Professors, and Medical Educators
• Pharmacologists and Pharmaceutical Researchers
• Biotechnology and Healthcare Technology Professionals
• Nurses and Allied Healthcare Professionals
• Medical Students and Early-Career Researchers
• Representatives from Public Health Organizations and Healthcare Institutions

As tuberculosis and respiratory infections continue to present significant challenges to global health, advances in early detection, effective treatment, infection prevention, antimicrobial stewardship, public health strategies, and innovative respiratory care remain essential. The 7th World Congress on Tuberculosis, Lung Infections, and Respiratory Care provides an international platform to exchange scientific knowledge, present research, discuss clinical challenges, explore emerging technologies, and foster collaboration among professionals working across respiratory medicine, infectious diseases, and public health.

Join us in Paris on April 29–30, 2027, where scientific research, clinical expertise, innovation, education, and global collaboration come together to explore the future of Tuberculosis, Lung Infections, and Respiratory Care and contribute to improved respiratory health outcomes worldwide.

Call for Abstracts

We invite pulmonologists, respiratory physicians, tuberculosis specialists, infectious disease specialists, respiratory therapists, researchers, academicians, clinicians, epidemiologists, public health professionals, and healthcare experts to submit abstracts for presentation at the 7th World Congress on Tuberculosis, Lung Infections, and Respiratory Care, taking place on April 29–30, 2027, in Paris, France.

This is an excellent opportunity to present innovative respiratory research, clinical experiences, evidence-based practices, emerging diagnostic technologies, advanced treatment approaches, public health strategies, and impactful case studies that are contributing to the prevention, diagnosis, management, and treatment of tuberculosis, lung infections, and respiratory diseases.

Share your knowledge, showcase your research and clinical expertise, and contribute to meaningful scientific discussions shaping the future of respiratory medicine, tuberculosis care, lung health, and respiratory healthcare worldwide.

Abstract Categories Include:

• Tuberculosis and Clinical TB Management
• Multidrug-Resistant and Drug-Resistant Tuberculosis
• Latent Tuberculosis Infection and Prevention
• TB Diagnosis and Molecular Diagnostics
• Pulmonary Tuberculosis and Extrapulmonary TB
• Tuberculosis Epidemiology and Public Health
• TB Infection Prevention and Control
• Antimicrobial Resistance and Respiratory Infections
• Bacterial, Viral, and Fungal Lung Infections
• Community-Acquired and Hospital-Acquired Pneumonia
• Respiratory Viral Infections and Emerging Pathogens
• Pulmonology and Clinical Respiratory Medicine
• Chronic Respiratory Diseases and Lung Health
• Asthma and Airway Diseases
• Chronic Obstructive Pulmonary Disease
• Interstitial Lung Diseases
• Occupational and Environmental Lung Diseases
• Sleep-Related Breathing Disorders
• Pulmonary Hypertension and Vascular Lung Diseases
• Critical Care and Respiratory Emergencies
• Mechanical Ventilation and Respiratory Support
• Pulmonary Rehabilitation and Respiratory Therapy
• Thoracic Imaging and Advanced Pulmonary Diagnostics
• Bronchoscopy and Interventional Pulmonology
• Artificial Intelligence and Digital Technologies in Respiratory Care
• Biomarkers and Precision Medicine in Pulmonary Diseases
• Novel Therapies and Drug Development
• Antimicrobial Stewardship and Treatment Strategies
• Respiratory Care in Vulnerable and High-Risk Populations
• Pediatric Respiratory Diseases and Lung Infections
• Geriatric Respiratory Health
• Smoking, Tobacco Control, and Lung Health
• Air Pollution, Climate Change, and Respiratory Health
• Global Respiratory Health and Health Equity
• Community-Based TB and Respiratory Disease Programs
• Evidence-Based Respiratory Medicine and Clinical Research
• Case Reports and Clinical Case Studies
• Emerging Trends and Innovations in Respiratory Care
• Student Research and Early-Career Respiratory Studies

Submission Guidelines:

• Abstracts must be written in English and structured with Background, Methods, Results, and Conclusion.
• Word limit: 250–300 words.
• All submissions must be original and unpublished at the time of submission.
• Authors may indicate their preferred presentation format: Oral Presentation, Poster Presentation, or Workshop Presentation.
• Multiple abstract submissions are welcome from individuals, hospitals, universities, research institutions, healthcare organizations, and research groups.

Visa Information for Attendees

We warmly welcome all international participants to the 7th World Congress on Tuberculosis, Lung Infections, and Respiratory Carehttps://tuberculosis.conferenceseries.com/abstract-submission.php, taking place in Paris, France, on April 29–30, 2027. To ensure a smooth and well-planned travel experience, we strongly recommend that attendees begin reviewing their visa requirements and preparing their travel documentation well in advance of the congress dates.

Early preparation can help participants allow sufficient time for document collection, appointment scheduling, and visa processing.

Do You Need a Visa to Enter France?

Participants traveling from non-Schengen countries may need to obtain a short-stay Schengen visa to attend the 7th World Congress on Tuberculosis, Lung Infections, and Respiratory Care in Paris. Visa requirements depend on nationality, travel purpose, duration of stay, and individual circumstances.

We recommend checking the official French visa authorities, France-Visas website, or the nearest French Embassy or Consulate for the most accurate and current information regarding your visa requirements.

Steps to Apply for a Schengen Visa for France

1. Check Visa Requirements

Review the official French visa information to determine whether you require a visa and identify the documentation and requirements applicable to your nationality and travel circumstances.

2. Gather Required Documents

• A valid passport with sufficient validity beyond your intended stay

• Completed visa application form

• Proof of accommodation

• Valid travel medical insurance

• Flight itinerary or travel reservation

• Official conference invitation letter, where applicable

• Proof of sufficient financial means

• Proof of employment, study, or professional status, where applicable

• Any additional documents requested by the French authorities

3. Request an Invitation Letter

After completing your conference registration, eligible participants may request an official invitation letter from the conference organizers. When requesting the letter, participants may be required to provide their full name, passport details, registration confirmation, and other relevant information.

4. Schedule a Visa Appointment

Book an appointment with the appropriate French Embassy, Consulate, or authorized visa application center in your country. Since appointment availability and processing times may vary, applicants are encouraged to begin the process as early as possible.

5. Attend the Visa Appointment

Submit your completed application together with all required supporting documents and provide biometric information, including fingerprints and a photograph, when required. Visa authorities may request additional documentation or information during the application process.

Important Notes

• The conference organizers are not authorized to influence or intervene in visa decisions. Eligible registered participants may receive appropriate conference documentation to support their visa application.

• Visa processing times may vary depending on the applicant's nationality, individual circumstances, application volume, and time of year. Applicants should consult the relevant French authorities for current processing information.

• Please ensure that your visa, if required, covers the entire period of your intended stay in the Schengen Area, including the congress dates and planned travel period.

• Visa approval is solely determined by the relevant French immigration and consular authorities.

• Participants are responsible for ensuring that they meet all applicable visa and entry requirements before traveling to France.

• Conference registration or an invitation letter does not guarantee visa approval.

Need Assistance?

For visa-related inquiries or assistance with obtaining your official conference invitation letter, please contact the conference support team. We will be happy to provide guidance regarding available conference documentation and registration requirements.

We look forward to welcoming you to Paris on April 29–30, 2027, for the 7th World Congress on Tuberculosis, Lung Infections, and Respiratory Care, where pulmonologists, respiratory physicians, tuberculosis specialists, researchers, clinicians, public health professionals, healthcare experts, and industry representatives will come together to share knowledge, exchange ideas, present research, and explore advances in tuberculosis, lung infections, respiratory medicine, and respiratory care.

Sessions & Tracks

Tuberculosis: Diagnosis, Treatment & Clinical Management

Tuberculosis remains a major infectious disease challenge requiring accurate diagnosis, effective treatment, and comprehensive patient management. Discussions cover pulmonary and extrapulmonary tuberculosis, clinical evaluation, diagnostic approaches, treatment strategies, treatment adherence, patient monitoring, and management of complications. Advances in clinical care and evidence-based approaches to improving treatment outcomes are emphasized.

Drug-Resistant & Multidrug-Resistant Tuberculosis

Drug-resistant tuberculosis presents complex challenges in diagnosis, treatment selection, disease control, and patient management. Discussions address multidrug-resistant and rifampicin-resistant TB, rapid detection of resistance, individualized treatment approaches, novel therapeutic regimens, treatment monitoring, adverse effects, and strategies for improving outcomes in drug-resistant disease.

Tuberculosis Diagnostics & Molecular Technologies

Rapid and accurate diagnosis is essential for effective tuberculosis control and timely treatment. Discussions focus on molecular diagnostic technologies, nucleic acid amplification tests, culture-based methods, drug susceptibility testing, biomarkers, rapid resistance detection, and advanced laboratory approaches. Integration of innovative diagnostic technologies into clinical and public health programs is highlighted.

TB Prevention, Screening & Infection Control

Effective prevention and early identification of tuberculosis are essential components of respiratory and public health programs. Discussions cover TB screening, contact investigation, latent tuberculosis infection, preventive therapy, airborne infection control, healthcare-associated transmission, risk assessment, and community-based prevention strategies.

Pulmonary Tuberculosis & Extrapulmonary TB

Tuberculosis can affect multiple organs and present with diverse clinical manifestations. Discussions cover pulmonary TB, pleural tuberculosis, lymphatic TB, central nervous system involvement, gastrointestinal and genitourinary tuberculosis, disseminated disease, diagnostic challenges, and multidisciplinary approaches to patient management.

Latent Tuberculosis Infection & Preventive Therapy

Identification and management of latent tuberculosis infection play an important role in reducing future disease burden. Discussions focus on screening high-risk populations, diagnostic testing, risk assessment, preventive treatment regimens, treatment adherence, monitoring, and strategies for integrating TB preventive services into healthcare systems.

Respiratory & Pulmonary Infections

Respiratory infections remain an important cause of illness across different populations and healthcare settings. Discussions address bacterial, viral, fungal, and other infectious diseases affecting the respiratory system, with emphasis on clinical presentation, diagnostic evaluation, antimicrobial treatment, prevention, complications, and patient-centered respiratory care.

Pneumonia & Lower Respiratory Tract Infections

Pneumonia and lower respiratory tract infections require timely diagnosis and appropriate treatment to reduce complications and mortality. Discussions cover community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, diagnostic strategies, antimicrobial therapy, resistant pathogens, supportive care, prevention, and clinical management.

Antimicrobial Resistance & Stewardship

Antimicrobial resistance continues to influence the management of tuberculosis and other respiratory infections. Discussions focus on resistant pathogens, appropriate antimicrobial selection, stewardship programs, treatment optimization, surveillance, diagnostic-guided therapy, infection prevention, and strategies to preserve antimicrobial effectiveness.

Pulmonology & Clinical Respiratory Medicine

Clinical respiratory medicine encompasses the diagnosis and management of a broad range of pulmonary conditions. Discussions cover respiratory symptoms, pulmonary function assessment, diagnostic pathways, chronic and acute respiratory disorders, multidisciplinary care, clinical decision-making, and advances in patient-centered pulmonary medicine.

Chronic Obstructive Pulmonary Disease

COPD represents a significant burden on individuals and healthcare systems worldwide. Discussions focus on disease diagnosis, spirometry, exacerbation management, pharmacological treatment, non-pharmacological interventions, pulmonary rehabilitation, smoking cessation, respiratory support, comorbidity management, and strategies for improving long-term outcomes.

Asthma & Airway Diseases

Asthma and other airway disorders require individualized approaches to diagnosis, treatment, and long-term disease control. Discussions address asthma phenotypes, biomarkers, inhaled therapies, severe asthma, biologic treatments, exacerbation prevention, airway inflammation, environmental triggers, and personalized respiratory care.

Interstitial Lung Diseases & Pulmonary Fibrosis

Interstitial lung diseases encompass diverse conditions associated with inflammation, fibrosis, and progressive respiratory impairment. Discussions cover diagnostic evaluation, high-resolution imaging, pulmonary function testing, multidisciplinary assessment, antifibrotic therapies, supportive care, disease monitoring, and emerging approaches for improving patient outcomes.

Pulmonary Hypertension & Vascular Lung Diseases

Pulmonary vascular disorders can significantly affect respiratory and cardiovascular function. Discussions address pulmonary hypertension classification, diagnostic evaluation, imaging, hemodynamic assessment, targeted therapies, right-heart function, associated pulmonary conditions, multidisciplinary management, and emerging therapeutic strategies.

Critical Care & Respiratory Emergencies

Severe respiratory diseases may require rapid assessment, intensive monitoring, and advanced supportive care. Discussions cover acute respiratory failure, severe pneumonia, critical respiratory infections, sepsis, acute exacerbations, emergency assessment, intensive care management, and multidisciplinary approaches to critically ill patients.

Mechanical Ventilation & Respiratory Support

Advanced respiratory support plays an important role in managing patients with acute and chronic respiratory failure. Discussions focus on invasive and non-invasive ventilation, high-flow oxygen therapy, ventilation strategies, weaning, respiratory monitoring, home ventilation, complications, and individualized approaches to respiratory support.

Interventional Pulmonology & Bronchoscopy

Interventional pulmonology provides advanced diagnostic and therapeutic approaches for complex respiratory conditions. Discussions cover bronchoscopy, endobronchial ultrasound, airway interventions, biopsy techniques, therapeutic bronchoscopy, airway obstruction, minimally invasive procedures, procedural safety, and advances in bronchoscopic technologies.

Thoracic Imaging & Advanced Pulmonary Diagnostics

Modern imaging technologies provide essential information for the diagnosis and monitoring of respiratory diseases. Discussions cover chest radiography, computed tomography, high-resolution CT, magnetic resonance imaging, lung ultrasound, image-guided procedures, radiological assessment, and integration of imaging with clinical and laboratory findings.

Pulmonary Function Testing & Respiratory Diagnostics

Accurate assessment of respiratory function supports diagnosis, disease monitoring, and treatment planning. Discussions cover spirometry, lung volumes, diffusion capacity, bronchial provocation testing, exercise testing, respiratory muscle assessment, interpretation of pulmonary function results, and emerging diagnostic technologies.

Respiratory Viruses & Emerging Infectious Diseases

Emerging and re-emerging respiratory pathogens continue to present challenges for healthcare systems and global health. Discussions address respiratory viral infections, emerging pathogens, outbreak preparedness, surveillance, rapid diagnostics, infection prevention, clinical management, vaccination strategies, and public health responses.

Fungal & Opportunistic Lung Infections

Fungal and opportunistic respiratory infections can cause serious disease, particularly among vulnerable and immunocompromised populations. Discussions cover pulmonary fungal diseases, invasive infections, diagnostic challenges, antifungal therapies, resistance, host factors, imaging findings, and multidisciplinary approaches to clinical management.

Pediatric Respiratory Diseases & Lung Infections

Respiratory disorders and infections remain important causes of illness among children. Discussions address pediatric pneumonia, childhood asthma, recurrent respiratory infections, congenital respiratory disorders, tuberculosis in children, diagnostic challenges, treatment approaches, prevention, and age-appropriate respiratory care.

Geriatric Respiratory Health

Respiratory disease management among older adults requires consideration of age-related physiological changes, multiple chronic conditions, and treatment complexity. Discussions cover COPD, pneumonia, tuberculosis, respiratory infections, frailty, polypharmacy, respiratory rehabilitation, prevention, supportive care, and strategies for maintaining respiratory health and quality of life.

Smoking, Tobacco Control & Lung Health

Tobacco exposure remains a major preventable contributor to respiratory disease and lung cancer. Discussions focus on smoking-related lung disease, tobacco cessation, nicotine dependence, prevention strategies, public health interventions, youth tobacco prevention, secondhand smoke exposure, and approaches to improving population respiratory health.

Air Pollution, Occupational & Environmental Lung Diseases

Environmental and occupational exposures can contribute to respiratory disease and long-term pulmonary impairment. Discussions address air pollution, particulate matter, occupational exposures, chemical and biological hazards, pneumoconiosis, occupational asthma, environmental risk assessment, prevention strategies, and public health approaches to reducing respiratory exposure risks.

Pulmonary Rehabilitation & Respiratory Therapy

Pulmonary rehabilitation supports functional capacity, symptom management, and quality of life among individuals with chronic respiratory conditions. Discussions cover exercise training, breathing techniques, nutritional support, respiratory therapy, patient education, psychological support, rehabilitation technologies, home-based programs, and individualized rehabilitation strategies.

Sleep Medicine & Sleep-Related Breathing Disorders

Sleep-related respiratory disorders can significantly affect health, wellbeing, and daytime functioning. Discussions cover obstructive sleep apnea, sleep-related hypoventilation, diagnostic sleep studies, positive airway pressure therapy, respiratory monitoring, treatment adherence, and multidisciplinary approaches to sleep and respiratory health.

Artificial Intelligence & Digital Health in Respiratory Care

Digital technologies and artificial intelligence are creating new opportunities for respiratory diagnosis, monitoring, prediction, and patient management. Discussions focus on AI-assisted imaging, predictive analytics, remote monitoring, digital therapeutics, telemedicine, wearable technologies, automated respiratory assessment, data integration, clinical validation, and responsible technology adoption.

Precision Medicine & Biomarkers in Pulmonary Diseases

Advances in molecular science and biomarker research are supporting more individualized approaches to respiratory disease management. Discussions cover molecular profiling, diagnostic biomarkers, predictive biomarkers, disease phenotyping, targeted therapies, personalized treatment strategies, and translational research in pulmonary and infectious diseases.

Novel Therapies & Emerging Treatment Strategies

Research into new therapeutic approaches continues to expand the options available for respiratory and infectious diseases. Discussions address novel antimicrobials, targeted therapies, immunomodulatory approaches, biologic therapies, drug development, combination treatments, treatment optimization, and emerging clinical evidence.

Global Tuberculosis Control & Public Health

Effective tuberculosis control requires coordinated clinical, community, and public health strategies. Discussions focus on global TB programs, disease surveillance, case detection, treatment access, contact tracing, preventive therapy, health-system strengthening, vulnerable populations, social determinants of health, and strategies for reducing the global burden of tuberculosis.

Respiratory Epidemiology & Disease Surveillance

Epidemiological research provides essential evidence for understanding disease patterns, risk factors, transmission, and healthcare needs. Discussions cover respiratory disease surveillance, outbreak monitoring, population studies, disease burden, risk assessment, epidemiological modeling, health data systems, and evidence-based public health planning.

Global Respiratory Health & Health Equity

Differences in access to diagnosis, treatment, prevention, and respiratory healthcare continue to influence health outcomes across populations. Discussions address healthcare disparities, access to essential medicines, respiratory workforce development, resource-limited settings, community-based care, health-system strengthening, and strategies supporting equitable respiratory healthcare.

Market Analysis

The global respiratory healthcare sector continues to evolve, driven by the ongoing burden of tuberculosis, lung infections, chronic respiratory diseases, antimicrobial resistance, and emerging respiratory conditions. Growing demand for early diagnosis, effective treatment, preventive care, and advanced respiratory services is supporting continued development across pulmonary and infectious disease healthcare.

Advancements in molecular diagnostics, rapid TB testing, advanced imaging, artificial intelligence, digital health, biomarkers, and precision medicine are transforming the diagnosis and management of respiratory diseases. These technologies are creating new opportunities to improve diagnostic accuracy, treatment planning, disease monitoring, and patient outcomes.

Healthcare systems are also placing greater emphasis on TB prevention, infection control, antimicrobial stewardship, respiratory rehabilitation, smoking cessation, and community-based care. Collaboration among hospitals, universities, research institutions, public health organizations, pharmaceutical companies, and healthcare technology providers is supporting innovation and knowledge exchange.

These developments highlight the importance of clinical research, professional education, technological innovation, evidence-based practice, and international collaboration. The 7th World Congress on Tuberculosis, Lung Infections, and Respiratory Care, taking place in Paris, France, on April 29–30, 2027, provides a platform for global professionals to exchange knowledge, present research, explore emerging developments, and advance respiratory healthcare worldwide.